• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    iHuman Inc. Announces Second Quarter 2023 Unaudited Financial Results

    9/21/23 4:22:00 AM ET
    $IH
    Other Consumer Services
    Real Estate
    Get the next $IH alert in real time by email

    BEIJING, Sept. 21, 2023 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the second quarter ended June 30, 2023.

    (PRNewsfoto/iHuman Inc.)

    Second Quarter 2023 Highlights

    • Revenues were RMB241.0 million (US$33.2 million), compared with RMB230.6 million in the same period last year.
    • Gross profit was RMB170.8 million (US$23.6 million), compared with RMB163.2 million in the same period last year.
    • Operating income was RMB40.9 million (US$5.6 million), a year-over-year increase of 80.8%.
    • Adjusted operating income[1] was RMB43.3 million (US$6.0 million), a year-over-year increase of 75.7%.
    • Net income was RMB42.1 million (US$5.8 million), a year-over-year increase of 93.1%.
    • Adjusted net income[1] was RMB44.5 million (US$6.1 million), a year-over-year increase of 86.8%.
    • Average total MAUs[2] for the second quarter were 20.33 million, a year-over-year increase of 11.7%.

    Dr. Peng Dai, Director and Chief Executive Officer of iHuman, commented, "Despite the impact of seasonality on our business, we are pleased to deliver another quarter of solid results, marked by year-over-year revenue improvement and enhanced profitability. This performance underscores the resilience of our business model and the effective execution by our team to further solidify our industry-leading position. During the quarter, we remained committed to our product-driven strategy and to strengthening our portfolio through a combination of cutting-edge technological innovation and captivating content. Domestically, we further optimized our comprehensive portfolio, rolling out enhancements to both newer releases and well-established core offerings. For example, within iHuman Little Artists, we launched "Interactive Art Gallery", an innovative module designed to introduce children to art and nurture their creativity through an integrated online-offline experience. Leveraging advanced technologies such as key point recognition, image segmentation and an AI-driven assessment engine, the module provides children with extensive support throughout their creative journey, including step-by-step instructions, instant and personalized feedback, and guidance from seasoned art professionals. Within our long-standing flagship app, iHuman Chinese, which is the prominent market leader in the category, we introduced a new module named "Chinese Characters in Daily Life." By integrating Chinese characters into everyday life scenarios and weaving them into intriguing short stories that resonate with children, the module strengthens children's familiarity and proficiency with Chinese characters in a fun way. Internationally, we continued to boost our market presence by diligently enriching our product offerings with enlightening content and innovative features. In particular, we expanded Aha World with two more highly engaging modules, "My World" and "City." Designed to further unleash children's creativity, these modules offer children a wide array of elements with which they can use their imagination to custom-design scenes from daily life in the virtual world. The open-ended creative experience offered by these modules received an enthusiastic reception from our young audience. Looking ahead, we will continue to focus on technological innovation and content excellence to secure the long-term success of our products and sustainable growth of our business."

    Ms. Vivien Weiwei Wang, Director and Chief Financial Officer of iHuman, added, "We reported another solid set of results which reflects our commitment and continued focus on driving sustainable growth and profitability. Our revenues continued to grow year-over-year and our net income nearly doubled, marking our sixth consecutive quarter of profitability. Our strong and balanced financial position enables us to continue investing in innovation and cutting-edge technologies to support the sustainable growth of our business. The solid foundation created by our user base is an integral driver for our long-term growth. During the quarter, our average total MAUs increased by 11.7% year-over-year to 20.33 million. We are encouraged by the strength and resilience of our diversified business and our ability to execute on our strategy to drive business growth. As we move into the second half of the year, we will continue to drive business growth and create value for our shareholders by further enhancing our operational efficiency and strategically investing in long-term growth opportunities, fortifying our industry-leading position."

    Second Quarter 2023 Unaudited Financial Results

    Revenues

    Revenues were RMB241.0 million (US$33.2 million), an increase of 4.5% from RMB230.6 million in the same period last year, primarily driven by user expansion and enhanced user engagement.

    Average total MAUs for the quarter were 20.33 million, an increase of 11.7% year-over-year from 18.20 million in the same period last year. The number of paying users[3] was 1.31 million.

    Cost of Revenues

    Cost of revenues was RMB70.2 million (US$9.7 million), an increase of 4.1% from RMB67.4 million in the same period last year.

    Gross Profit and Gross Margin

    Gross profit was RMB170.8 million (US$23.6 million), an increase of 4.7% from RMB163.2 million in the same period last year. Gross margin was 70.9%, maintaining approximately the same level from 70.8% in the same period last year.

    Operating Expenses

    Total operating expenses were RMB130.0 million (US$17.9 million), a decrease of 7.6% from RMB140.6 million in the same period last year.

    Research and development expenses were RMB63.4 million (US$8.7 million), a decrease of 18.9% from RMB78.2 million in the same period last year, primarily due to payroll-related cost savings and decreased outsourcing expenses as a result of the continued optimization of our operational efficiency.

    Sales and marketing expenses were RMB40.6 million (US$5.6 million), an increase of 21.0% from RMB33.5 million in the same period last year, primarily due to increased strategic spending on promotional activities.

    General and administrative expenses were RMB26.0 million (US$3.6 million), compared with RMB28.8 million in the same period last year.

    Operating Income 

    Operating income was RMB40.9 million (US$5.6 million), an increase of 80.8% from RMB22.6 million in the same period last year.

    Excluding share-based compensation expenses, adjusted operating income was RMB43.3 million (US$6.0 million), an increase of 75.7% from RMB24.6 million in the same period last year.

    Net Income 

    Net income was RMB42.1 million (US$5.8 million), an increase of 93.1% from RMB21.8 million in the same period last year.

    Adjusted net income was RMB44.5 million (US$6.1 million), an increase of 86.8% from RMB23.8 million in the same period last year.

    Basic and diluted net income per ADS were RMB0.80 (US$0.11) and RMB0.77 (US$0.11), respectively, compared with RMB0.41 and RMB0.40 in the same period last year. Each ADS represents five Class A ordinary shares of the Company.

    Adjusted diluted net income per ADS was RMB0.81 (US$0.11), compared with RMB0.44 in the same period last year.

    Deferred Revenue and Customer Advances

    Deferred revenue and customer advances were RMB325.8 million (US$44.9 million) as of June 30, 2023, compared with RMB379.1 million as of December 31, 2022.

    Cash, Cash Equivalents and Time Deposits

    Cash, cash equivalents and time deposits were RMB1,104.8 million (US$152.4 million) as of June 30, 2023, compared with RMB1,050.0 million as of December 31, 2022.

    [1] "Adjusted operating income" and "adjusted net income" exclude share-based compensation expenses. Please see "Non-GAAP Financial Measures" and "Unaudited Reconciliation of GAAP and non-GAAP Results" at the end of this press release.

    [2] "Average total MAUs" refers to the monthly average of the sum of the MAUs of each of the Company's apps during a specific period, which is counted based on the number of unique mobile devices through which such app is accessed at least once in a given month, and duplicate access to different apps is not eliminated from the total MAUs calculation.

    [3]  "Paying users" refers to users who paid subscription fees for premium content on any of the Company's apps during a specific period; a user who makes payments across different apps using the same registered account is counted as one paying user, and a user who makes payments for the same app multiple times in the same period is counted as one paying user.

    Exchange Rate Information

    The U.S. dollar (US$) amounts disclosed in this press release, except for those transaction amounts that were actually settled in U.S. dollars, are presented solely for the convenience of the reader. The conversion of Renminbi (RMB) into US$ in this press release is based on the exchange rate set forth in the H.10 statistical release of the Board of Governors of the Federal Reserve System as of June 30, 2023, which was RMB7.2513 to US$1.00. The percentages stated in this press release are calculated based on the RMB amounts.

    Non-GAAP Financial Measures

    iHuman considers and uses non-GAAP financial measures, such as adjusted operating income, adjusted net income and adjusted diluted net income per ADS, as supplemental metrics in reviewing and assessing its operating performance and formulating its business plan. The presentation of non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). iHuman defines adjusted operating income, adjusted net income and adjusted diluted net income per ADS as operating income, net income and diluted net income per ADS excluding share-based compensation expenses, respectively. Adjusted operating income, adjusted net income and adjusted diluted net income per ADS enable iHuman's management to assess its operating results without considering the impact of share-based compensation expenses, which are non-cash charges. iHuman believes that these non-GAAP financial measures provide useful information to investors in understanding and evaluating the Company's current operating performance and prospects in the same manner as management does, if they so choose.

    Non-GAAP financial measures are not defined under U.S. GAAP and are not presented in accordance with U.S. GAAP. Non-GAAP financial measures have limitations as analytical tools, which possibly do not reflect all items of expense that affect our operations. Share-based compensation expenses have been and may continue to be incurred in our business and are not reflected in the presentation of the non-GAAP financial measures. In addition, the non-GAAP financial measures iHuman uses may differ from the non-GAAP measures used by other companies, including peer companies, and therefore their comparability may be limited. The presentation of these non-GAAP financial measures is not intended to be considered in isolation from or as a substitute for the financial information prepared and presented in accordance with GAAP.

    Safe Harbor Statement

    This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates"  and similar statements. Statements that are not historical facts, including statements about iHuman's beliefs and expectations, are forward-looking statements. Among other things, the description of the management's quotations in this announcement contains forward-looking statements. iHuman may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the "SEC"), in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: iHuman's growth strategies; its future business development, financial condition and results of operations; its ability to continue to attract and retain users, convert non-paying users into paying users and increase the spending of paying users, the trends in, and size of, the market in which iHuman operates; its expectations regarding demand for, and market acceptance of, its products and services; its expectations regarding its relationships with business partners; general economic and business conditions; regulatory environment; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in iHuman's filings with the SEC. All information provided in this press release is as of the date of this press release, and iHuman does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

    About iHuman Inc.

    iHuman Inc. is a leading provider of tech-powered, intellectual development products in China that is committed to making the child-upbringing experience easier for parents and transforming cognitive development into a fun journey for children. Benefiting from a deep legacy that combines over two decades of experience in the parenthood industry, superior original content, advanced high-tech innovation DNA and research & development capabilities with cutting-edge technologies, iHuman empowers parents with tools to make the child-upbringing experience more efficient. iHuman's unique, fun and interactive product offerings stimulate children's natural curiosity and exploration. The Company's comprehensive suite of innovative and high-quality products include self-directed apps, interactive content and smart devices that cover a broad variety of areas to develop children's abilities in speaking, critical thinking, independent reading and creativity, and foster their natural interest in traditional Chinese culture. Leveraging advanced technological capabilities, including 3D engines, AI/AR functionality, and big data analysis on children's behavior & psychology, iHuman believes it will continue to provide superior experience that is efficient and relieving for parents, and effective and fun for children, in China and all over the world, through its integrated suite of tech-powered, intellectual development products.

    For more information about iHuman, please visit https://ir.ihuman.com/.

    For investor and media enquiries, please contact:

    iHuman Inc.

    Mr. Justin Zhang

    Investor Relations Director

    Phone: +86 10 5780-6606

    E-mail: [email protected] 

    Christensen

    In China

    Mr. Eric Yuan

    Phone: +86-13801110739

    E-mail: [email protected]  

    In the US

    Ms. Linda Bergkamp

    Phone: +1-480-614-3004

    E-mail: [email protected]  

     

     

     

    iHuman Inc.

    UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

    (Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

    except for number of shares, ADSs, per share and per ADS data)





    December 31,



    June 30,



    June 30,



    2022



    2023



    2023



    RMB



    RMB



    US$













    ASSETS











    Current assets











    Cash and cash equivalents 

    1,049,999



    967,472



    133,420

    Time deposits

    -



    137,290



    18,933

    Accounts receivable, net

    79,614



    58,982



    8,134

    Inventories, net

    19,127



    15,144



    2,088

    Amounts due from related parties

    2,286



    1,780



    245

    Prepayments and other current assets

    102,765



    92,630



    12,774

    Total current assets

    1,253,791



    1,273,298



    175,594

    Non-current assets











    Property and equipment, net

    9,205



    7,284



    1,005

    Intangible assets, net

    24,872



    24,707



    3,407

    Operating lease right-of-use assets

    12,782



    3,626



    500

    Long-term investment

    26,333



    26,333



    3,631

    Other non-current assets

    6,416



    6,659



    922

    Total non-current assets

    79,608



    68,609



    9,465

    Total assets

    1,333,399



    1,341,907



    185,059













    LIABILITIES











    Current liabilities











    Accounts payable

    24,206



    20,198



    2,785

    Deferred revenue and customer advances

    379,063



    325,828



    44,934

    Amounts due to related parties

    6,944



    3,529



    487

    Accrued expenses and other current liabilities

    144,717



    110,440



    15,230

    Current operating lease liabilities

    6,123



    1,566



    216

    Total current liabilities

    561,053



    461,561



    63,652

    Non-current liabilities











    Non-current operating lease liabilities

    2,894



    2,267



    313

    Total non-current liabilities

    2,894



    2,267



    313

    Total liabilities

    563,947



    463,828



    63,965

    SHAREHOLDERS' EQUITY











    Ordinary shares (par value of US$0.0001 per share,

        700,000,000 Class A shares authorized as of December

        31, 2022 and June 30, 2023; 125,122,382 Class A shares

        issued and 121,722,467 outstanding as of December 31,

        2022; 125,122,382 Class A shares issued and
    119,857,402

        outstanding as of June 30, 2023; 200,000,000 Class B

        shares authorized, 144,000,000 Class B ordinary shares

        issued and outstanding as of December 31, 2022 and June

        30, 2023; 100,000,000 shares (undesignated) authorized,

        nil shares (undesignated) issued and outstanding as of

        December 31, 2022 and June 30, 2023)

    185



    185



    26

    Additional paid-in capital

    1,079,099



    1,083,937



    149,482

    Treasury stock

    (7,123)



    (15,592)



    (2,150)

    Statutory reserves

    7,967



    7,967



    1,099

    Accumulated other comprehensive income

    10,497



    27,035



    3,728

    Accumulated deficit

    (321,173)



    (225,453)



    (31,091)

    Total shareholders' equity

    769,452



    878,079



    121,094

    Total liabilities and shareholders' equity

    1,333,399



    1,341,907



    185,059

     

     

     

    iHuman Inc.

    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

    except for number of shares, ADSs, per share and per ADS data)





    For the three months ended



    For the six months ended



    June 30,



    March 31,



    June 30,



    June 30,



    June 30,



    June 30,



    June 30,



    2022



    2023



    2023



    2023



    2022



    2023



    2023



    RMB



    RMB



    RMB



    US$



    RMB



    RMB



    US$





























    Revenues

    230,607



    265,203



    240,993



    33,234



    473,286



    506,196



    69,808

    Cost of revenues

    (67,417)



    (79,636)



    (70,160)



    (9,676)



    (140,214)



    (149,796)



    (20,658)





























    Gross profit

    163,190



    185,567



    170,833



    23,558



    333,072



    356,400



    49,150





























    Operating expenses



























    Research and development expenses

    (78,201)



    (61,673)



    (63,412)



    (8,745)



    (174,826)



    (125,085)



    (17,250)

    Sales and marketing expenses

    (33,530)



    (40,435)



    (40,564)



    (5,594)



    (69,436)



    (80,999)



    (11,170)

    General and administrative expenses

    (28,849)



    (26,735)



    (25,982)



    (3,583)



    (54,907)



    (52,717)



    (7,270)

    Total operating expenses

    (140,580)



    (128,843)



    (129,958)



    (17,922)



    (299,169)



    (258,801)



    (35,690)

    Operating income

    22,610



    56,724



    40,875



    5,636



    33,903



    97,599



    13,460

    Other income, net

    2,917



    6,082



    8,132



    1,121



    6,264



    14,214



    1,960

    Income before income taxes

    25,527



    62,806



    49,007



    6,757



    40,167



    111,813



    15,420

    Income tax expenses

    (3,737)



    (9,160)



    (6,933)



    (956)



    (5,259)



    (16,093)



    (2,219)

    Net income

    21,790



    53,646



    42,074



    5,801



    34,908



    95,720



    13,201





























    Net income per ADS:



























       - Basic

    0.41



    1.01



    0.80



    0.11



    0.66



    1.81



    0.25

       - Diluted

    0.40



    0.98



    0.77



    0.11



    0.64



    1.75



    0.24





























    Weighted average number of ADSs:



























       - Basic

    53,308,924



    52,953,297



    52,804,594



    52,804,594



    53,392,158



    52,878,535



    52,878,535

       - Diluted

    53,958,284



    54,763,570



    54,725,528



    54,725,528



    54,009,098



    54,744,139



    54,744,139





























    Total share-based compensation expenses included in:



























    Cost of revenues

    39



    98



    70



    10



    103



    168



    23

    Research and development expenses

    801



    638



    1,142



    157



    1,768



    1,780



    245

    Sales and marketing expenses

    430



    379



    59



    8



    342



    438



    60

    General and administrative expenses

    762



    1,292



    1,160



    160



    1,776



    2,452



    338





























     

     

     

    iHuman Inc.

    UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP RESULTS

    (Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

    except for number of shares, ADSs, per share and per ADS data)









    For the three months ended



    For the six months ended







    June 30,



    March 31,



    June 30,



    June 30,



    June 30,



    June 30,



    June 30,







    2022



    2023



    2023



    2023



    2022



    2023



    2023







    RMB



    RMB



    RMB



    US$



    RMB



    RMB



    US$

































    Operating income





    22,610



    56,724



    40,875



    5,636



    33,903



    97,599



    13,460

    Share-based compensation expenses





    2,032



    2,407



    2,431



    335



    3,989



    4,838



    666

    Adjusted operating income





    24,642



    59,131



    43,306



    5,971



    37,892



    102,437



    14,126

































    Net income





    21,790



    53,646



    42,074



    5,801



    34,908



    95,720



    13,201

    Share-based compensation expenses





    2,032



    2,407



    2,431



    335



    3,989



    4,838



    666

    Adjusted net income





    23,822



    56,053



    44,505



    6,136



    38,897



    100,558



    13,867

































    Diluted net income per ADS





    0.40



    0.98



    0.77



    0.11



    0.64



    1.75



    0.24

    Impact of non-GAAP adjustments





    0.04



    0.04



    0.04



    0.00



    0.08



    0.09



    0.01

    Adjusted diluted net income per ADS





    0.44



    1.02



    0.81



    0.11



    0.72



    1.84



    0.25

































    Weighted average number of ADSs – diluted





    53,958,284



    54,763,570



    54,725,528



    54,725,528



    54,009,098



    54,744,139



    54,744,139

    Weighted average number of ADSs – adjusted





    53,958,284



    54,763,570



    54,725,528



    54,725,528



    54,009,098



    54,744,139



    54,744,139

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ihuman-inc-announces-second-quarter-2023-unaudited-financial-results-301934486.html

    SOURCE iHuman Inc.

    Get the next $IH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IH

    DatePrice TargetRatingAnalyst
    12/30/2022$3.10Buy
    Citigroup
    More analyst ratings

    $IH
    SEC Filings

    View All

    SEC Form 6-K filed by iHuman Inc.

    6-K - iHuman Inc. (0001814423) (Filer)

    12/29/25 7:33:02 AM ET
    $IH
    Other Consumer Services
    Real Estate

    SEC Form 6-K filed by iHuman Inc.

    6-K - iHuman Inc. (0001814423) (Filer)

    9/18/25 7:08:02 AM ET
    $IH
    Other Consumer Services
    Real Estate

    SEC Form 6-K filed by iHuman Inc.

    6-K - iHuman Inc. (0001814423) (Filer)

    6/26/25 7:54:57 AM ET
    $IH
    Other Consumer Services
    Real Estate

    $IH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    iHuman Inc. Announces Third Quarter 2025 Unaudited Financial Results

    BEIJING, Dec. 29, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights Revenues were RMB205.8 million (US$28.9 million), compared with RMB239.4 million in the same period last year.Gross profit was RMB140.6 million (US$19.8 million), compared with RMB163.9 million in the same period last year.Operating income was RMB16.7 million (US$2.3 million), compared

    12/29/25 4:11:00 AM ET
    $IH
    Other Consumer Services
    Real Estate

    iHuman Inc. Announces Second Quarter 2025 Unaudited Financial Results

    BEIJING, Sept. 18, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights Revenues were RMB200.2 million (US$27.9 million), compared with RMB215.1 million in the same period last year.Gross profit was RMB135.7 million (US$19.0 million), compared with RMB151.7 million in the same period last year.Operating income was RMB19.5 million (US$2.7 million), compared wi

    9/18/25 4:30:00 AM ET
    $IH
    Other Consumer Services
    Real Estate

    iHuman and Cricket Media Team Up to Launch Reading Stars

    Reading Stars seamlessly merges Cricket's award-winning content with iHuman's cutting-edge technology, creating an entirely new way for children to engage with reading. BEIJING and MCLEAN, Va., Sept. 18, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH), a leading provider of tech‑powered, intellectual development products in China, and Cricket Media, whose magazines have delighted families for more than 50 years, today announced the global launch of Reading Stars. Drawing on iHuman's expertise in content digitalization, edutainment and interactive learning design, along with Cricket Media's extensive library, the app transforms traditional reading resources into a dynamic digital experience that

    9/18/25 4:00:00 AM ET
    $IH
    Other Consumer Services
    Real Estate

    $IH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup resumed coverage on iHuman with a new price target

    Citigroup resumed coverage of iHuman with a rating of Buy and set a new price target of $3.10

    12/30/22 8:45:58 AM ET
    $IH
    Other Consumer Services
    Real Estate

    $IH
    Financials

    Live finance-specific insights

    View All

    iHuman Inc. Announces Third Quarter 2025 Unaudited Financial Results

    BEIJING, Dec. 29, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights Revenues were RMB205.8 million (US$28.9 million), compared with RMB239.4 million in the same period last year.Gross profit was RMB140.6 million (US$19.8 million), compared with RMB163.9 million in the same period last year.Operating income was RMB16.7 million (US$2.3 million), compared

    12/29/25 4:11:00 AM ET
    $IH
    Other Consumer Services
    Real Estate

    iHuman Inc. Announces Second Quarter 2025 Unaudited Financial Results

    BEIJING, Sept. 18, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights Revenues were RMB200.2 million (US$27.9 million), compared with RMB215.1 million in the same period last year.Gross profit was RMB135.7 million (US$19.0 million), compared with RMB151.7 million in the same period last year.Operating income was RMB19.5 million (US$2.7 million), compared wi

    9/18/25 4:30:00 AM ET
    $IH
    Other Consumer Services
    Real Estate

    iHuman Inc. Announces First Quarter 2025 Unaudited Financial Results

    BEIJING, June 26, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Revenues were RMB210.4 million (US$29.0 million), compared with RMB235.0 million in the same period last year.Gross profit was RMB143.8 million (US$19.8 million), compared with RMB168.1 million in the same period last year.Operating income was RMB21.6 million (US$3.0 million), compared with

    6/26/25 6:12:00 AM ET
    $IH
    Other Consumer Services
    Real Estate

    $IH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by iHuman Inc. (Amendment)

    SC 13G/A - iHuman Inc. (0001814423) (Subject)

    3/8/22 10:06:04 AM ET
    $IH
    Other Consumer Services
    Real Estate

    SEC Form SC 13G/A filed by iHuman Inc. (Amendment)

    SC 13G/A - iHuman Inc. (0001814423) (Subject)

    2/14/22 4:13:25 PM ET
    $IH
    Other Consumer Services
    Real Estate

    SEC Form SC 13G filed

    SC 13G - iHuman Inc. (0001814423) (Subject)

    2/16/21 6:11:44 AM ET
    $IH
    Other Consumer Services
    Real Estate